EuropaBio names Rappagliosi chairman
This article was originally published in Scrip
EuropaBio, the European association for bioindustries, elected Dr Andrea Rappagliosi chairman at its annual general assembly yesterday in Brussels. He succeeds Steen Riisgaard, president and CEO of Novozymes, and will serve a two-year term.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.